Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?

NCT00259168 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Insulin Resistance
Impaired Fasting Glucose

Interventions

DRUG: Nateglinide

Sponsor

Atheline Major-Pedersen

Collaborators

[object Object]
[object Object]